The hypothesis that CXCL16 released from tumor cells acts in an autocrine/paracrine way to promote tumor progression is further confirmed by the significant reduction in tumor volume, proliferation, and infiltration in mice bearing glioma cells silenced for CXCL16. Here, CXCL16 is linked to neoplasm.